| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
I. Medizinische Klinik, Medizinische Hochschule Lübeck [T. W.], and Zentrum der Biologischen Chemie, Universität Frankfurt am Main [G. P., G. V., H. J. H.], Federal Republic of Germany
An assay for the characterization and quantitative determination of activated cyclophosphamide has been described. The method is based on high reactivity of the kryptaldehyde group in 4-hydroxycyclophosphamide with mercapto compounds to yield 4-(S-R)mercaptocyclophosphamide derivatives. The activated cyclophosphamide can be converted quantitatively to 4-(S-benzyl)mercaptocyclophosphamide with benzyl mercaptan, and the mercapto derivative can be separated by thin-layer chromatography on silica gel with ethyl acetate:methyl ethyl ketone as solvent. Using this assay, significant levels of activated cyclophosphamide in the blood of mice and rats, as well as of humans, were found to be present after cyclophosphamide application. The characterization of 4-(S-benzyl)mercaptocyclophosphamide formed was confirmed by comparing the thin-layer chromatographic and mass spectrometric data on this derivative obtained from an authentic sample of 4-hydroxycyclophosphamide.
1 Supported by Bundesministerium für wissenschaftliche Forschung und Technologie. Bonn-Bad Godesberg, and Hessischer Landesverband für Krebsbekämpfung, Frankfurt am Main, West Germany.
2 To whom requests for reprints should be addressed, at Zentrum der Biologischen Chemie, Theodor-Stem-Kai 7, D-6000 Frankfurt am Main, Federal Republic of Germany.
Received 10/ 5/76. Accepted 5/10/77.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |